Lyell Immunopharma Inc (LYEL) Directors and Executive Officers - CSIMarket
CSIMarket
 
Lyell Immunopharma Inc   (NASDAQ: LYEL)

Lyell Immunopharma Inc

Officers & Directors


Executives:

William Rieflin - Director

Richard D. Klausner - Chair of the Board of Directors

Charles Newton - Chief Financial Officer

Otis Brawley - Director

Hans Bishop - Director

Catherine Friedman - Director

Lynn Seely - President, Chief Executive Officer and Director

Elizabeth Nabel - Director

Robert Nelsen - Director

Directors:

- William Rieflin
- Richard D. Klausner
- Otis Brawley
- Hans Bishop
- Catherine Friedman
- Elizabeth Nabel
- Robert Nelsen

- Lynn Seely,

Lyell Immunopharma Inc currently has 161 employees.






LYEL Management Effectiveness LYEL Revenue per Employee LYEL Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.